Related Experiment Videos
Coronary dilatory capacity in idiopathic dilated cardiomyopathy: analysis of 16 patients
Insights
Idiopathic dilated cardiomyopathy (IDC) impairs coronary dilatory capacity, showing reduced blood flow during vasodilation. This is linked to increased coronary resistance and elevated left ventricular end-diastolic pressure in IDC patients.
Area of Science:
- Cardiology
- Physiology
Background:
- Idiopathic dilated cardiomyopathy (IDC) is a significant cause of heart failure.
- Assessing coronary blood flow dynamics is crucial for understanding cardiac function in IDC.
Purpose of the Study:
- To investigate coronary blood flow and resistance during maximal vasodilation in patients with IDC.
- To correlate hemodynamic parameters with coronary vascular function in IDC.
Main Methods:
- Coronary blood flow measured using the argon technique in 16 IDC patients and 12 controls.
- Maximal inducible coronary vasodilation induced by dipyridamole (0.5 mg/kg).
- Hemodynamic parameters including left ventricular (LV) end-diastolic pressure and ejection fraction were assessed.
Main Results:
- Coronary blood flow was normal at rest but significantly reduced during dipyridamole vasodilation in IDC patients compared to controls.
- Minimal coronary resistance was significantly increased in IDC patients.
- IDC patients exhibited increased LV end-diastolic pressure and diminished LV ejection fraction.
- LV end-diastolic pressure strongly correlated with minimal coronary resistance post-dipyridamole.
Conclusions:
- Coronary dilatory capacity is impaired in patients with IDC.
- Increased extravascular resistance contributes to impaired coronary vasodilation in IDC.
- Findings suggest a link between impaired coronary vasodilation and cardiac dysfunction in IDC.
Abstract:
Hemodynamic function and overall coronary blood flow (argon technique) were measured in 16 patients with idiopathic dilated cardiomyopathy (IDC) and in 12 patients without detectable heart disease (control subjects) referred for precordial pain. In patients with IDC, coronary blood flow was normal at rest (78 +/- 17 ml/100 g-min versus 78 +/- 9 in control subjects). During maximal inducible coronary vasodilation (dipyridamole, 0.5 mg/kg), coronary blood flow was significantly reduced (142 +/- 38 ml/100 g.min versus 301 +/- 64 in control subjects; p less than 0.001). Consequently, obtainable minimal coronary resistance was increased in IDC (0.54 +/- 0.20 mm Hg/ml/100 g.min versus 0.23 +/- 0.04 in control subjects; p less than 0.001). In patients with IDC, left ventricular (LV) end-diastolic pressure was significantly increased (19 +/- 11 mm Hg versus 6 +/- 3 in control subjects; p less than 0.005), and the LV ejection fraction was diminished (36 +/- 11% versus 72 +/- 3% in control subjects; p less than 0.001). In patients with IDC, LV end-diastolic pressure correlated significantly with the obtained minimal coronary resistance after application of dipyridamole (r = 0.85; p less than 0.001). LV catheter biopsy specimens revealed no alterations in myocardial microvasculature. Thus, coronary dilatory capacity is impaired in patients with IDC, due partially to an increase in extravascular component of coronary resistance.